$PTGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Protagonist Therapeutics, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Protagonist Therapeutics, Inc. Get notifications about new insider transactions in Protagonist Therapeutics, Inc for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 28 2021 | PTGX | Protagonist Therap ... | Williams Lewis T | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
| May 28 2021 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
| May 28 2021 | PTGX | Protagonist Therap ... | O'Dowd Sarah A | Director | Option Exercise | A | 35.23 | 18,000 | 634,140 | 18,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 23.57 | 90,000 | 2,121,300 | 90,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Grant | A | 0.00 | 12,000 | 0 | 14,000 | 2 K to 14 K (+600.00 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 23.57 | 225,000 | 5,303,250 | 225,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 451,144 | 426.1 K to 451.1 K (+5.87 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 23.57 | 65,000 | 1,532,050 | 65,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 10,000 | 0 | 62,427 | 52.4 K to 62.4 K (+19.07 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Option Exercise | A | 23.57 | 55,000 | 1,296,350 | 55,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Grant | A | 0.00 | 7,500 | 0 | 10,386 | 2.9 K to 10.4 K (+259.88 %) |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Gupta Suneel | Chief Development O ... | Option Exercise | A | 23.57 | 80,000 | 1,885,600 | 80,000 | |
| Feb 26 2021 | PTGX | Protagonist Therap ... | Gupta Suneel | Chief Development O ... | Grant | A | 0.00 | 12,000 | 0 | 63,987 | 52 K to 64 K (+23.08 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 3,700 | 25,826 | 3,600 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | M | 6.98 | 4,700 | 32,806 | 7,300 | |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 25.09 | 3,700 | 92,833 | 0 | 3.7 K to 0 (-100.00 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Grant | A | 6.98 | 3,700 | 25,826 | 3,700 | 0 to 3.7 K |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 26.04 | 400 | 10,416 | 0 | 400 to 0 (-100.00 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Sell | S | 25.42 | 4,300 | 109,306 | 400 | 4.7 K to 400 (-91.49 %) |
| Feb 12 2021 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Grant | A | 6.98 | 4,700 | 32,806 | 4,700 | 0 to 4.7 K |
| Jan 20 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 4.21 | 13,000 | 54,730 | 165,742 | |
| Jan 20 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 24.60 | 24,846 | 611,105 | 426,144 | 451 K to 426.1 K (-5.51 %) |
| Jan 20 2021 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 4.21 | 13,000 | 54,730 | 450,990 | 438 K to 451 K (+2.97 %) |
| Aug 18 2020 | PTGX | Protagonist Therap ... | O'Dowd Sarah A | Director | Option Exercise | A | 16.50 | 30,000 | 495,000 | 30,000 | |
| Aug 12 2020 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | M | 1.89 | 2,499 | 4,723 | 7,499 | |
| Aug 12 2020 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Sell | S | 17.19 | 2,499 | 42,952 | 0 | 2.5 K to 0 (-100.00 %) |
| Aug 12 2020 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Buy | M | 1.89 | 2,499 | 4,723 | 2,499 | 0 to 2.5 K |
| May 29 2020 | PTGX | Protagonist Therap ... | Williams Lewis T | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 29 2020 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 29 2020 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 29 2020 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 29 2020 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 29 2020 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 16.54 | 15,000 | 248,100 | 15,000 | |
| May 01 2020 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Gift | G | 0.00 | 2,000 | 0 | 437,990 | 440 K to 438 K (-0.45 %) |
| Apr 08 2020 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 9.99 | 5,000 | 49,950 | 5,000 | |
| Mar 23 2020 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.89 | 10,000 | 18,900 | 34,087 | |
| Mar 23 2020 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.89 | 10,000 | 18,900 | 439,990 | 430 K to 440 K (+2.33 %) |
| Mar 13 2020 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.16 | 18,344 | 21,279 | 0 | |
| Mar 13 2020 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.16 | 18,344 | 21,279 | 429,990 | 411.6 K to 430 K (+4.46 %) |
| Mar 12 2020 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Buy | P | 6.70 | 12,000 | 80,400 | 15,310 | 3.3 K to 15.3 K (+362.54 %) |
| Feb 28 2020 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 7.80 | 85,000 | 663,000 | 85,000 | |
| Feb 28 2020 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 7.80 | 235,000 | 1,833,000 | 235,000 | |
| Feb 28 2020 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 7.80 | 70,000 | 546,000 | 70,000 | |
| Feb 28 2020 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Option Exercise | A | 7.80 | 55,000 | 429,000 | 55,000 | |
| Feb 28 2020 | PTGX | Protagonist Therap ... | Gupta Suneel | Chief Development O ... | Option Exercise | A | 7.80 | 85,000 | 663,000 | 85,000 | |
| Dec 03 2019 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Buy | P | 5.70 | 8,000 | 45,620 | 8,000 | 0 to 8 K |
| Dec 03 2019 | PTGX | Protagonist Therap ... | Gupta Suneel | EVP Clinical Operat ... | Buy | P | 5.13 | 30,000 | 153,900 | 49,500 | 19.5 K to 49.5 K (+153.85 %) |
| Dec 03 2019 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Buy | P | 5.09 | 562 | 2,861 | 1,175 | 613 to 1.2 K (+91.68 %) |
| Dec 03 2019 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Buy | P | 5.10 | 613 | 3,126 | 613 | 0 to 613 |
| Dec 03 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | P | 5.65 | 20,000 | 113,000 | 409,824 | 389.8 K to 409.8 K (+5.13 %) |
| Dec 03 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | P | 5.55 | 10,000 | 55,500 | 389,824 | 379.8 K to 389.8 K (+2.63 %) |
| Nov 27 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.16 | 4,000 | 4,640 | 18,343 | |
| Nov 27 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.16 | 4,000 | 4,640 | 379,824 | 375.8 K to 379.8 K (+1.06 %) |
| Aug 08 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 8.85 | 3,395 | 30,044 | 49,802 | 53.2 K to 49.8 K (-6.38 %) |
| Aug 08 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 8.85 | 10,792 | 95,535 | 374,792 | 385.6 K to 374.8 K (-2.80 %) |
| Jun 11 2019 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 11 2019 | PTGX | Protagonist Therap ... | Williams Lewis T | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 11 2019 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 11 2019 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 11 2019 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 11 2019 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 11.80 | 12,000 | 141,600 | 12,000 | |
| Jun 03 2019 | PTGX | Protagonist Therap ... | Kalkofen Donald A. | Chief Financial Off ... | Option Exercise | A | 10.06 | 100,000 | 1,006,000 | 100,000 | |
| May 16 2019 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Medical Offic ... | Option Exercise | A | 10.80 | 45,000 | 486,000 | 45,000 | |
| Apr 02 2019 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Option Exercise | M | 1.31 | 3,310 | 4,336 | 0 | |
| Apr 02 2019 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Buy | M | 1.31 | 3,310 | 4,336 | 3,310 | 0 to 3.3 K |
| Apr 02 2019 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 6.45 | 3,000 | 19,350 | 3,000 | |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 8.02 | 90,000 | 721,800 | 90,000 | |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 8.03 | 810 | 6,504 | 51,197 | 52 K to 51.2 K (-1.56 %) |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 15,000 | 0 | 52,007 | 37 K to 52 K (+40.53 %) |
| Mar 04 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 8.02 | 172,500 | 1,383,450 | 172,500 | |
| Mar 04 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 8.03 | 2,183 | 17,529 | 383,831 | 386 K to 383.8 K (-0.57 %) |
| Mar 04 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Grant | A | 0.00 | 28,750 | 0 | 386,014 | 357.3 K to 386 K (+8.05 %) |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Development O ... | Option Exercise | A | 8.02 | 15,000 | 120,300 | 15,000 | |
| Mar 04 2019 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Development O ... | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
| Feb 08 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 7.71 | 10,132 | 78,118 | 357,264 | 367.4 K to 357.3 K (-2.76 %) |
| Feb 08 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 8.10 | 777 | 6,292 | 367,396 | 368.2 K to 367.4 K (-0.21 %) |
| Feb 08 2019 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 7.74 | 3,821 | 29,562 | 37,007 | 40.8 K to 37 K (-9.36 %) |
| Feb 08 2019 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Sell | S | 7.71 | 2,580 | 19,892 | 24,178 | 26.8 K to 24.2 K (-9.64 %) |
| Feb 08 2019 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Sell | S | 8.15 | 198 | 1,614 | 26,758 | 27 K to 26.8 K (-0.73 %) |
| Jan 16 2019 | PTGX | Protagonist Therap ... | Gupta Suneel | EVP Clinical Operat ... | Option Exercise | M | 7.38 | 110,000 | 811,800 | 110,000 | |
| Jan 14 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.16 | 22,344 | 25,919 | 22,343 | |
| Jan 14 2019 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.16 | 22,344 | 25,919 | 368,173 | 345.8 K to 368.2 K (+6.46 %) |
| Aug 17 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 8.58 | 14,050 | 120,549 | 14,050 | |
| Aug 17 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Grant | A | 0.00 | 21,100 | 0 | 30,560 | 9.5 K to 30.6 K (+223.04 %) |
| Aug 17 2018 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Option Exercise | A | 8.58 | 12,500 | 107,250 | 12,500 | |
| Aug 17 2018 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Grant | A | 0.00 | 18,750 | 0 | 26,956 | 8.2 K to 27 K (+228.49 %) |
| Aug 17 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 8.58 | 54,700 | 469,326 | 54,700 | |
| Aug 17 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Grant | A | 0.00 | 82,050 | 0 | 345,829 | 263.8 K to 345.8 K (+31.11 %) |
| Aug 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 8.58 | 17,200 | 147,576 | 17,200 | |
| Aug 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 25,800 | 0 | 40,828 | 15 K to 40.8 K (+171.68 %) |
| Jul 13 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Gift | G | 0.00 | 2,000 | 0 | 263,779 | 265.8 K to 263.8 K (-0.75 %) |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Williams Lewis T | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Waddill William D. | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Shanafelt Armen | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | SELICK HAROLD E | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Noonberg Sarah B. | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | KHOSLA CHAITAN PHD | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| Jun 12 2018 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 6.98 | 12,000 | 83,760 | 12,000 | |
| May 31 2018 | PTGX | Protagonist Therap ... | Saks Samuel R | Chief Development O ... | Option Exercise | A | 7.28 | 50,000 | 364,000 | 50,000 | |
| May 21 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.09 | 38,968 | 237,358 | 2,116,552 | 2.2 M to 2.1 M (-1.81 %) |
| May 17 2018 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Option Exercise | A | 6.45 | 24,000 | 154,800 | 24,000 | |
| May 17 2018 | PTGX | Protagonist Therap ... | Giraudo Bryan | Director | Buy | P | 6.46 | 10,000 | 64,566 | 10,000 | 0 to 10 K |
| May 16 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.46 | 29,441 | 190,071 | 2,155,520 | 2.2 M to 2.2 M (-1.35 %) |
| May 16 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.48 | 57,715 | 374,080 | 2,184,961 | 2.2 M to 2.2 M (-2.57 %) |
| May 16 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.37 | 77,591 | 494,224 | 2,242,676 | 2.3 M to 2.2 M (-3.34 %) |
| May 11 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.16 | 13,516 | 15,679 | 44,687 | |
| May 11 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.16 | 13,516 | 15,679 | 265,779 | 252.3 K to 265.8 K (+5.36 %) |
| Mar 28 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 0.87 | 11,298 | 9,829 | 0 | |
| Mar 28 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 0.87 | 11,298 | 9,829 | 232,263 | 221 K to 232.3 K (+5.11 %) |
| Mar 26 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.71 | 59,950 | 1,241,325 | 2,320,267 | 2.4 M to 2.3 M (-2.52 %) |
| Mar 22 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.62 | 4,759 | 98,133 | 2,380,217 | 2.4 M to 2.4 M (-0.20 %) |
| Mar 22 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.61 | 17,699 | 364,727 | 2,384,976 | 2.4 M to 2.4 M (-0.74 %) |
| Mar 22 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.61 | 17,060 | 351,538 | 2,402,675 | 2.4 M to 2.4 M (-0.71 %) |
| Mar 19 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.57 | 13,439 | 276,446 | 2,419,735 | 2.4 M to 2.4 M (-0.55 %) |
| Mar 19 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.51 | 6,926 | 142,063 | 2,433,174 | 2.4 M to 2.4 M (-0.28 %) |
| Mar 15 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.64 | 11,751 | 242,521 | 2,440,100 | 2.5 M to 2.4 M (-0.48 %) |
| Mar 15 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.77 | 200 | 4,154 | 2,451,851 | 2.5 M to 2.5 M (-0.01 %) |
| Mar 15 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.84 | 1,204 | 25,094 | 2,452,051 | 2.5 M to 2.5 M (-0.05 %) |
| Mar 13 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 4.21 | 3,500 | 14,735 | 35,331 | |
| Mar 13 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 21.29 | 3,500 | 74,500 | 15,028 | 18.5 K to 15 K (-18.89 %) |
| Mar 13 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 4.21 | 3,500 | 14,735 | 18,528 | 15 K to 18.5 K (+23.29 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Option Exercise | A | 16.95 | 37,500 | 635,625 | 37,500 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Grant | A | 0.00 | 6,500 | 0 | 6,500 | 0 to 6.5 K |
| Mar 02 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | A | 16.95 | 150,000 | 2,542,500 | 150,000 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Grant | A | 0.00 | 25,000 | 0 | 219,259 | 194.3 K to 219.3 K (+12.87 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | A | 16.95 | 34,000 | 576,300 | 34,000 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Grant | A | 0.00 | 6,000 | 0 | 8,858 | 2.9 K to 8.9 K (+209.94 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 9,725 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | A | 16.95 | 56,500 | 957,675 | 56,500 | |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 13,322 | 14.2 K to 13.3 K (-6.16 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 875 | 1,654 | 14,197 | 13.3 K to 14.2 K (+6.57 %) |
| Mar 02 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Grant | A | 0.00 | 9,500 | 0 | 13,322 | 3.8 K to 13.3 K (+248.56 %) |
| Jan 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 10,600 | |
| Jan 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 3,822 | 4.7 K to 3.8 K (-18.63 %) |
| Jan 17 2018 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 875 | 1,654 | 4,697 | 3.8 K to 4.7 K (+22.89 %) |
| Dec 27 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Option Exercise | M | 4.21 | 3,529 | 14,857 | 33,273 | |
| Dec 27 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Sell | S | 20.50 | 3,529 | 72,345 | 0 | 3.5 K to 0 (-100.00 %) |
| Dec 27 2017 | PTGX | Protagonist Therap ... | Shames Richard S. | Chief Medical Offic ... | Buy | M | 4.21 | 3,529 | 14,857 | 3,529 | 0 to 3.5 K |
| Dec 21 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.89 | 8,210 | 15,517 | 44,087 | |
| Dec 21 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 19.56 | 8,210 | 160,570 | 190,437 | 198.6 K to 190.4 K (-4.13 %) |
| Dec 21 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.89 | 8,210 | 15,517 | 198,647 | 190.4 K to 198.6 K (+4.31 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Option Exercise | M | 1.89 | 1,790 | 3,383 | 52,297 | |
| Dec 20 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Sell | S | 19.55 | 1,790 | 34,987 | 190,437 | 192.2 K to 190.4 K (-0.93 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | PATEL DINESH V PH D | President and CEO | Buy | M | 1.89 | 1,790 | 3,383 | 192,227 | 190.4 K to 192.2 K (+0.94 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Option Exercise | M | 1.89 | 875 | 1,654 | 11,475 | |
| Dec 20 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Sell | S | 20.00 | 875 | 17,500 | 3,822 | 4.7 K to 3.8 K (-18.63 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | Liu David Y | Chief Scientific Of ... | Buy | M | 1.89 | 875 | 1,654 | 4,697 | 3.8 K to 4.7 K (+22.89 %) |
| Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 4.21 | 4,000 | 16,840 | 28,998 | |
| Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Option Exercise | M | 1.16 | 4,000 | 4,640 | 57,666 | |
| Dec 20 2017 | PTGX | Protagonist Therap ... | O'Neil Thomas P. | Chief Financial Off ... | Sell | S | 20.00 | 8,000 | 160,000 | 0 | 8 K to 0 (-100.00 %) |